Presentation and Status in Health Basket
Presentation | Basket | Yarpa | Pharmasoft |
---|---|---|---|
Transdermal Patch 5 X 12.5 µg/hr (2.1 mg/patch) |
59911 | ||
Transdermal Patch 5 X 25 µg/hr (4.2 mg/patch) |
59912 | ||
Transdermal Patch 5 X 50 µg/hr (8.4 mg/patch) |
59913 | ||
Transdermal Patch 5 X 75 µg/hr (12.6 mg/patch) |
59914 | ||
Transdermal Patch 5 X 100 µg/hr (16.8 mg/patch) |
59915 |
Related information
Dosage
Each patch is intended for 3 days of treatment (72 hours) only. The patch should be Replaced every 72 hours, unless the doctor has instructed otherwise. Due to slow absorption of the medicine to the skin, the effect of the preparation may not be apparent immediately after applying the first patch. Sometimes, the maximal effect is only apparent 24 hours after applying the first patch. Therefore, additional painkillers on the first day of treatment may be needed.
See prescribing information for full details.
Indications
Management of chronic pain and intractable pain requiring opioid analgesia. Fentadol should only be used in patients who are already receiving opioid therapy, who have demonstrated opioid tolerance.
Contra-Indications
Hypersensitivity to active substance or any of the excipients. Patients who did not use an opioid analgesic in the past. Short period pain (e.g., after surgery). Patients with not chronic/persistent pain. Mild or moderate pain relief. Patients with severe breathing problems. Patients with severe impairment of the central nervous system function (e.g., brain damage). During treatment with monoamine oxidase (MAO) inhibitors, or within a minimum of 2 weeks of discontinuing those drugs. Lactation. Children under 2 years of age.